Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19. Even before the lockdown began, Nucleome Therapeutics, Alchemab Therapeutics and Hutano Diagnostics all quickly redirected their scientific expertise and business plans. These rapid innovations were achieved through collaborations with nearby experts, highlighting the importance of knowledge sharing in solving urgent healthcare problems.
Agile start-ups partner with academics to find COVID-19 solutions
Coronavirus COVID-19 General Innovation Research
16 July 2020
Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.
